ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1,4,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1,5,Normal pressure hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
2,1,Parotid gland enlargement,Salivary gland enlargements,Salivary gland conditions,Gastr,N
2,2,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
3,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
4,1,Oculogyric crisis,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
5,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
6,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
6,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
6,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
6,4,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
7,1,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
8,1,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
9,1,Myelitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
10,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
12,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
13,1,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
14,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
14,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
15,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
16,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
17,1,Demyelinating polyneuropathy,Chronic polyneuropathies,Peripheral neuropathies,Nerv,N
18,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
18,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
18,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
19,1,Tachyarrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
19,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
20,1,Jaundice hepatocellular,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
21,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
22,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
22,2,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
22,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
23,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
24,1,Headache,Headaches NEC,Headaches,Nerv,N
25,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
26,1,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
27,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
27,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
28,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
28,2,Vitamin B12 deficiency,Water soluble vitamin deficiencies,Vitamin related disorders,Metab,N
29,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
29,2,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
29,3,Headache,Headaches NEC,Headaches,Nerv,N
29,4,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
29,5,Hyperventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
29,6,Respiratory alkalosis,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
29,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
30,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,Y
30,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
31,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,Y
32,1,Emphysema,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
32,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
33,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
33,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
34,1,Mesothelioma,Mesotheliomas malignant and unspecified,Mesotheliomas,Neopl,Y
35,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
35,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
35,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
35,4,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
35,5,Uterine atony,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
36,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
37,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
38,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
38,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
38,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
38,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
39,1,Emphysema,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
40,1,Subcutaneous emphysema,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
41,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
42,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
43,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
43,2,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
43,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
44,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
44,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
44,3,PO2 decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
44,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
45,1,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
45,2,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
45,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
46,1,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
47,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
47,2,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
47,3,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
48,1,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
48,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
48,3,Myelopathy,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
48,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
48,5,Toxic neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
48,6,Vitamin B12 deficiency,Water soluble vitamin deficiencies,Vitamin related disorders,Metab,N
49,1,Pulse absent,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
49,2,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
50,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
51,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
51,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
52,1,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
53,1,Chronic respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
53,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
53,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
53,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
53,5,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
54,1,Hypercapnia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
55,1,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
56,1,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
57,1,Carbon dioxide increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
57,2,Hypercapnia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
57,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
57,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
57,5,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
58,1,Inadequate analgesia,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
58,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
58,3,Sedation complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
59,1,Inadequate analgesia,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
59,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
59,3,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
60,1,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
61,1,Dextrocardia,Cardiac malpositions congenital,Cardiac and vascular disorders congenital,Cong,N
61,2,Foetal alcohol syndrome,Chemically-induced congenital syndromes,Congenital and hereditary disorders NEC,Cong,N
61,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
61,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
61,5,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
62,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
62,2,Chest expansion decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
62,3,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
62,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
62,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
62,6,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
62,7,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
62,8,Postmature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
62,9,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
62,10,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
62,11,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
63,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
64,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
65,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
65,2,Chest expansion decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
65,3,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
65,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
65,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
65,6,Maternal exposure timing unspecified,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
65,7,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
65,8,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
65,9,PCO2 decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
65,10,PO2 decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
65,11,Prolonged pregnancy,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
65,12,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
65,13,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
65,14,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
65,15,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
66,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
66,2,Ischaemia,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
66,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
66,4,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
66,5,Venous thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
66,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
67,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
68,1,Carbon dioxide increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
68,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
69,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
69,2,Transient global amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
70,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
70,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
70,3,Sensation of foreign body,Feelings and sensations NEC,General system disorders NEC,Genrl,N
71,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
71,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
72,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
72,2,Enlarged uvula,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
72,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
72,4,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
73,1,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
74,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
75,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
75,2,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
76,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
76,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
77,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
78,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
79,1,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
80,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
80,2,Hypercapnia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
81,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
81,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
81,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
81,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
82,1,Clumsiness,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
82,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
82,3,Headache,Headaches NEC,Headaches,Nerv,N
82,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
82,5,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
82,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
82,7,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
83,1,Hypercapnia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
83,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
83,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
84,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
84,2,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
85,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
85,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
85,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
86,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
86,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
86,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
86,4,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
86,5,Verbal abuse,Criminal activity,Legal issues,SocCi,N
87,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
87,2,Airway burns,Thermal burns,Injuries by physical agents,Inj&P,Y
87,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
88,1,Folate deficiency,Water soluble vitamin deficiencies,Vitamin related disorders,Metab,N
88,2,Subacute combined cord degeneration,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
88,3,Vitamin B12 deficiency,Water soluble vitamin deficiencies,Vitamin related disorders,Metab,N
89,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
89,2,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
90,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
91,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
92,1,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
93,1,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
93,2,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
94,1,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
95,1,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
96,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
96,2,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
97,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
97,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
97,3,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
98,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
98,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
98,3,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
99,1,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
100,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
101,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
102,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
103,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
103,2,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
104,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
104,2,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
105,1,Burn oral cavity,Thermal burns,Injuries by physical agents,Inj&P,N
105,2,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
106,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
106,2,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,Y
107,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
107,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
107,3,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
108,1,Device use error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
108,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
108,3,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
108,4,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
109,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
109,2,Headache,Headaches NEC,Headaches,Nerv,N
109,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
109,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
109,5,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
110,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
110,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
111,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
111,2,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
112,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
112,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
113,1,"Brief psychotic disorder, with postpartum onset",Brief psychotic disorder,Schizophrenia and other psychotic disorders,Psych,N
114,1,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
114,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
115,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
115,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
115,3,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
116,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
116,2,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
117,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
117,2,Headache,Headaches NEC,Headaches,Nerv,N
117,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
117,4,Nasal dryness,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
118,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
118,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
119,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
119,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
119,3,Pulseless electrical activity,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
120,1,Carbon dioxide increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
121,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
121,2,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
122,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
122,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
123,1,Vitamin B12 deficiency,Water soluble vitamin deficiencies,Vitamin related disorders,Metab,N
124,1,Device issue,Device issues NEC,Device issues,Prod,Y
125,1,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
125,2,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
125,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
126,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
126,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
126,3,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
127,1,Burns second degree,Thermal burns,Injuries by physical agents,Inj&P,N
128,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
128,2,Hypercapnia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
129,1,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
130,1,Biopsy kidney abnormal,Urinary tract histopathology procedures,Renal and urinary tract investigations and urinalyses,Inv,N
130,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
130,3,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
130,4,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
130,5,Herpes simplex reactivation,Herpes viral infections,Viral infectious disorders,Infec,N
130,6,Herpes simplex test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
130,7,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
130,8,Mucocutaneous haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
130,9,Pyelonephritis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
130,10,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
130,11,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
130,12,Streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
131,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
131,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
131,3,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
132,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
133,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
134,1,Accidental underdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
134,2,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
135,1,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
136,1,Burns first degree,Thermal burns,Injuries by physical agents,Inj&P,N
136,2,Burns second degree,Thermal burns,Injuries by physical agents,Inj&P,N
136,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
136,4,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
137,1,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
138,1,Burn infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
138,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
138,3,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
139,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
139,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
139,3,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
139,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
139,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
140,1,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
141,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
141,2,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
142,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
143,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
143,2,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,Y
144,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
144,2,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
145,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
145,2,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
146,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
146,2,Device catching fire,Device issues NEC,Device issues,Prod,N
147,1,Device catching fire,Device issues NEC,Device issues,Prod,N
147,2,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
148,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
148,2,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
149,1,Accidental underdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
149,2,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
149,3,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
150,1,PCO2,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
151,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
152,1,"Hallucinations, mixed",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
153,1,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
154,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
154,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
154,3,Screaming,General signs and symptoms NEC,General system disorders NEC,Genrl,N
155,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
155,2,Injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
155,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
156,1,Cluster headache,Headaches NEC,Headaches,Nerv,N
156,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
157,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
158,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
159,1,Accidental underdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
159,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
159,3,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
160,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
160,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
161,1,Device catching fire,Device issues NEC,Device issues,Prod,N
161,2,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
161,3,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
162,1,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
163,1,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
164,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
164,2,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
165,1,Accidental underdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
165,2,Body temperature decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
165,3,Device issue,Device issues NEC,Device issues,Prod,N
165,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
165,5,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
166,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
166,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
167,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
167,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
168,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
168,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
169,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
169,2,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
170,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
170,2,Burns second degree,Thermal burns,Injuries by physical agents,Inj&P,N
170,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
171,1,Accidental underdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
171,2,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
171,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
172,1,Hypercapnia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
172,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
172,3,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
173,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
173,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
173,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
173,4,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
173,5,Subacute combined cord degeneration,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
173,6,Vitamin B12 deficiency,Water soluble vitamin deficiencies,Vitamin related disorders,Metab,N
174,1,Device catching fire,Device issues NEC,Device issues,Prod,N
174,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
174,3,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
175,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
175,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
176,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
177,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
177,2,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,Y
178,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
178,2,Pulmonary haemorrhage neonatal,Newborn respiratory disorders NEC,Neonatal respiratory disorders,Resp,Y
179,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
180,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
180,2,Device catching fire,Device issues NEC,Device issues,Prod,N
180,3,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
180,4,Traumatic shock,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
181,1,Accidental underdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
181,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
181,3,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
182,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
183,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
183,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
183,3,Respiratory fume inhalation disorder,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
183,4,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
184,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
185,1,Hypercapnia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
185,2,Wrong dose,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
186,1,Exposure via skin contact,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
186,2,Frostbite,Conditions caused by cold,Injuries by physical agents,Inj&P,N
186,3,Occupational exposure to product,Occupational exposures,"Exposures, chemical injuries and poisoning",Inj&P,N
187,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
187,2,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
188,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
189,1,Respiration abnormal,Breathing abnormalities,Respiratory disorders NEC,Resp,N
190,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
191,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
192,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
192,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
193,1,Respiration abnormal,Breathing abnormalities,Respiratory disorders NEC,Resp,N
194,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
194,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
195,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
195,2,Maternal exposure during delivery,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
195,3,Pneumomediastinum,Mediastinal disorders,Thoracic disorders (excl lung and pleura),Resp,N
195,4,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
195,5,Subcutaneous emphysema,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
196,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
197,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
197,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
197,3,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
197,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
197,5,Procedural vomiting,Gastrointestinal and hepatobiliary procedural complications,Procedural related injuries and complications NEC,Inj&P,N
198,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
198,2,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
199,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
199,2,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
200,1,Headache,Headaches NEC,Headaches,Nerv,N
200,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
200,3,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
201,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
202,1,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
203,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
204,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
204,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
204,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
204,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
204,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
205,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
206,1,Headache,Headaches NEC,Headaches,Nerv,N
207,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
207,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
207,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
207,4,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
207,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
208,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
208,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
209,1,Circumstance or information capable of leading to device use error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
209,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
210,1,Headache,Headaches NEC,Headaches,Nerv,N
210,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
210,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
211,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
212,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
213,1,Hypercapnia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
213,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
214,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
214,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
214,3,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
215,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
215,2,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
216,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
216,2,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
217,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
217,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
218,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
218,2,Respiratory tract operation,Respiratory tract therapeutic procedures NEC,Respiratory tract therapeutic procedures,Surg,N
219,1,Accidental underdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
219,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
220,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
220,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
221,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
221,2,Device catching fire,Device issues NEC,Device issues,Prod,N
221,3,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
222,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
222,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
222,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
222,4,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
222,5,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
223,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
223,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
224,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
224,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
224,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
225,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
225,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
225,3,Injection related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
225,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
225,5,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
225,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
225,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
226,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
226,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
226,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
227,1,Accidental underdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
227,2,Device issue,Device issues NEC,Device issues,Prod,N
227,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
228,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
228,2,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
229,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
230,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
231,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
231,2,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
231,3,Headache,Headaches NEC,Headaches,Nerv,N
231,4,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
231,5,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
231,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
231,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
232,1,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
232,2,Suspected product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
233,1,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
234,1,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
235,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
235,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
236,1,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
236,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
236,3,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
237,1,Injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
237,2,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
238,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
238,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
238,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
239,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
239,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
240,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
240,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
240,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
240,4,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
241,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
241,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
241,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
241,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
242,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
242,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
243,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
243,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
243,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
244,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
244,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
244,3,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
244,4,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
244,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
245,1,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
245,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
245,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
245,4,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
246,1,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,Y
246,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
246,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
247,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
247,2,Product caught fire,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
247,3,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
248,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
248,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
249,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
249,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
249,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
249,4,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
249,5,Product caught fire,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
249,6,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
250,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
250,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
250,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
251,1,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
251,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
251,3,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
252,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
252,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
252,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
253,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
253,2,Cold burn,Thermal burns,Injuries by physical agents,Inj&P,N
253,3,Exposure via skin contact,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
254,1,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
254,2,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
254,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
255,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
255,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
256,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
256,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
256,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
257,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
257,2,Exposure via skin contact,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
257,3,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
258,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
258,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
258,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
258,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
259,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
259,2,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
259,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
260,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
260,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
261,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
261,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
262,1,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
262,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
263,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
263,2,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
264,1,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
264,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
265,1,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
265,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
265,3,Product taste abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
266,1,Headache,Headaches NEC,Headaches,Nerv,N
266,2,Hypercapnia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
266,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
266,4,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
266,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
267,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
267,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
267,3,Exposure via skin contact,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
267,4,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
267,5,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
268,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
268,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
269,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
270,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
270,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
271,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
271,2,Device defective,Device physical property and chemical issues,Device issues,Prod,N
271,3,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
272,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
273,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
274,1,Headache,Headaches NEC,Headaches,Nerv,N
274,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
275,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
275,2,Suspected product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
276,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
276,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
277,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
277,2,Product caught fire,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
277,3,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
278,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
278,2,Headache,Headaches NEC,Headaches,Nerv,N
279,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
279,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
279,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
279,4,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
280,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
280,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
281,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
281,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
281,3,Cold burn,Thermal burns,Injuries by physical agents,Inj&P,N
282,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
282,2,Intentional underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
283,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
283,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
283,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
284,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
285,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
285,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
286,1,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
286,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
287,1,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
287,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
288,1,Device leakage,Device issues NEC,Device issues,Prod,N
288,2,Injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
288,3,Occupational exposure to product,Occupational exposures,"Exposures, chemical injuries and poisoning",Inj&P,N
289,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
289,2,Burns first degree,Thermal burns,Injuries by physical agents,Inj&P,N
289,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
289,4,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
289,5,Product caught fire,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
289,6,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
289,7,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
290,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
290,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
290,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
290,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
291,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
291,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
292,1,Grunting,Breathing abnormalities,Respiratory disorders NEC,Resp,N
292,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
292,3,Suspected product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
293,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
293,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
294,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
294,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
294,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
295,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
295,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
296,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
296,2,Exposure via skin contact,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
296,3,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
297,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
297,2,Exposure via skin contact,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
297,3,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
298,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
298,2,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
298,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
299,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,Y
299,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
299,3,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
299,4,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
300,1,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
300,2,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
301,1,Nasal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
302,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
302,2,Exposure via skin contact,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
302,3,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
302,4,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
303,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
303,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
303,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
303,4,Exposure via skin contact,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
303,5,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
304,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
304,2,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
305,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
305,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
305,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
305,4,Exposure via skin contact,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
305,5,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
306,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
307,1,Headache,Headaches NEC,Headaches,Nerv,N
308,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
308,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
308,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
309,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
310,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
310,2,Airway burns,Thermal burns,Injuries by physical agents,Inj&P,N
310,3,Exposure via skin contact,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
310,4,Product caught fire,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
310,5,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
310,6,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
311,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
311,2,Refusal of treatment by patient,Social issues NEC,Lifestyle issues,SocCi,N
312,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
312,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
313,1,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
313,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
314,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
314,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
315,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
315,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
315,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
315,4,Suspected product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
316,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
316,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
316,3,Headache,Headaches NEC,Headaches,Nerv,N
316,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
316,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
317,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
317,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
317,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
318,1,Face injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
318,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
319,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
319,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
319,3,Product caught fire,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
319,4,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
320,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
320,2,Headache,Headaches NEC,Headaches,Nerv,N
320,3,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
321,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
321,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
322,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
322,2,Enterococcal infection,Enterococcal infections,Bacterial infectious disorders,Infec,N
322,3,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
322,4,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
322,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
322,6,Inflammation,Inflammations,General system disorders NEC,Genrl,N
322,7,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
322,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
322,9,Raoultella ornithinolytica infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
322,10,Serratia sepsis,Serratia infections,Bacterial infectious disorders,Infec,N
322,11,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
323,1,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
323,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
324,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
324,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
324,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
325,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
325,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
325,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
326,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
326,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
326,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
326,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
327,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
327,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
328,1,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
328,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
329,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
329,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
329,3,Exposure via skin contact,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
329,4,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
330,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
330,2,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
331,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
331,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
332,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
332,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
332,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
333,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
333,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
334,1,Agonal respiration,Breathing abnormalities,Respiratory disorders NEC,Resp,N
334,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
334,3,Hypercapnia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
334,4,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
335,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
336,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
336,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
337,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
338,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
338,2,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
339,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
339,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
339,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
340,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
340,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
341,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
341,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
342,1,Cluster headache,Headaches NEC,Headaches,Nerv,N
342,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
343,1,Headache,Headaches NEC,Headaches,Nerv,N
344,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
344,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
345,1,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
346,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
347,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
347,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
347,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
347,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
348,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,Y
348,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
349,1,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
349,2,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
349,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
350,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
350,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
351,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
351,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
352,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
352,2,Parosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
352,3,Product after taste,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
353,1,Headache,Headaches NEC,Headaches,Nerv,N
354,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
355,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
355,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
356,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
356,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
357,1,Infantile vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
357,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
357,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
357,4,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
358,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
358,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
359,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
359,2,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
360,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
360,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
360,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
361,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
361,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
362,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
363,1,Gastric dilatation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
363,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
364,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
364,2,Exposure via skin contact,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
364,3,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
364,4,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
365,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
365,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,Y
365,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
366,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
367,1,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
368,1,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
369,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
370,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
370,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
371,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
371,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
372,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
373,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
374,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
374,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
375,1,Derealisation,Perception disturbances NEC,Disturbances in thinking and perception,Psych,N
375,2,Dissociation,Dissociative states,Dissociative disorders,Psych,N
375,3,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
375,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
376,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
377,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
377,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
377,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
378,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
378,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
379,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
379,2,Exposure via skin contact,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
379,3,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
380,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
380,2,Joint injury,Bone and joint injuries NEC,Bone and joint injuries,Inj&P,N
380,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
380,4,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
381,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
381,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
381,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
381,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
382,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
383,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
383,2,Exposure via skin contact,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
383,3,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
384,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,Y
384,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
384,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
385,1,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
385,2,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
386,1,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
387,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
388,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
388,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
389,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
389,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
389,3,Exposure via skin contact,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
389,4,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
390,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
391,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
392,1,Extremity necrosis,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
392,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
392,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
393,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
394,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
394,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,Y
395,1,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
395,2,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
396,1,Craniofacial fracture,"Skull fractures, facial bone fractures and dislocations",Bone and joint injuries,Inj&P,N
396,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
396,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
397,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
398,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
398,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
399,1,Hypercapnia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
400,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
400,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
401,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
401,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
401,3,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
401,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
402,1,Headache,Headaches NEC,Headaches,Nerv,N
402,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
403,1,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
404,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
404,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
404,3,Cold burn,Thermal burns,Injuries by physical agents,Inj&P,N
404,4,Exposure via skin contact,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
404,5,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
404,6,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
405,1,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
406,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
407,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
407,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
408,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
409,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
409,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
410,1,Choking sensation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
410,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
410,3,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
411,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
411,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
412,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
412,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
413,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
413,2,Cold burn,Thermal burns,Injuries by physical agents,Inj&P,N
413,3,Exposure via skin contact,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
413,4,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
414,1,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
415,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
415,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
416,1,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
417,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
417,2,Product leakage,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
418,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
418,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
419,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
419,2,Headache,Headaches NEC,Headaches,Nerv,N
419,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
420,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
420,2,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
421,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
421,2,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
422,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
422,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
423,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
423,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
424,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
425,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
425,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,Y
426,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
426,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
426,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
426,4,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
427,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
427,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
428,1,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
429,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
429,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
430,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
430,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
430,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
431,1,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
432,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
432,2,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
432,3,Product odour abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
433,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
433,2,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
433,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
433,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
434,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
435,1,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
436,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
436,2,Dissociative disorder,Dissociative states,Dissociative disorders,Psych,N
436,3,Therapeutic product effect prolonged,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
436,4,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
437,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
437,2,Exposure via skin contact,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
437,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
437,4,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
438,1,Headache,Headaches NEC,Headaches,Nerv,N
438,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
439,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
440,1,Cold burn,Thermal burns,Injuries by physical agents,Inj&P,N
441,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
442,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
443,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
444,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
444,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
445,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
445,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
445,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
445,4,Oxygen saturation abnormal,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
446,1,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,Y
447,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
447,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
447,3,Product leakage,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
447,4,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
448,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
448,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
448,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
449,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
450,1,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
451,1,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
452,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
452,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
453,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
453,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
454,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
454,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
454,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
454,4,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
455,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
456,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
457,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
457,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
458,1,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
459,1,"Hallucinations, mixed",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
460,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
460,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
460,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
461,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
461,2,Cold burn,Thermal burns,Injuries by physical agents,Inj&P,N
462,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
462,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
462,3,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
463,1,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
464,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
465,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
465,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
465,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
466,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
466,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
467,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
467,2,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
468,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
469,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
469,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
469,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
469,4,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
469,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
469,6,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
469,7,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
469,8,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
470,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
470,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
470,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
471,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
472,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
472,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
473,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
473,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
473,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
473,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
474,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
474,2,Suffocation feeling,Respiratory signs and symptoms NEC,Respiratory tract signs and symptoms,Resp,N
475,1,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
476,1,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
476,2,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
477,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
477,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
477,3,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
478,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
478,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
478,3,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
478,4,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
479,1,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
479,2,Feeling drunk,Feelings and sensations NEC,General system disorders NEC,Genrl,N
479,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
480,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
481,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
481,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
482,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
483,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
483,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
483,3,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
483,4,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
484,1,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
484,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
485,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
485,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
485,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
485,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
486,1,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
486,2,Product odour abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
487,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
487,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
487,3,Sopor,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
488,1,Bradyphrenia,Thinking disturbances,Disturbances in thinking and perception,Psych,N
488,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
488,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
488,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
489,1,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
489,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
490,1,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
490,2,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
490,3,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
490,4,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
490,5,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
490,6,Thinking abnormal,Thinking disturbances,Disturbances in thinking and perception,Psych,N
490,7,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
491,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
491,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
491,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
492,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
492,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
493,1,Headache,Headaches NEC,Headaches,Nerv,N
493,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
494,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
494,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
494,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
495,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
495,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
495,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
495,4,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
495,5,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
496,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
497,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
497,2,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
497,3,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
498,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
498,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
498,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
498,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
498,5,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
498,6,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
499,1,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
499,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
500,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
500,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
500,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
501,1,Disinhibition,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
501,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
501,3,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
501,4,Sedation complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
502,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
502,2,Cold burn,Thermal burns,Injuries by physical agents,Inj&P,N
502,3,Exposure via skin contact,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
502,4,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
503,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
503,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
504,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
504,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
505,1,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
506,1,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
507,1,Cold burn,Thermal burns,Injuries by physical agents,Inj&P,N
507,2,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
508,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
509,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
509,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
509,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
509,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
509,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
510,1,Crepitations,General signs and symptoms NEC,General system disorders NEC,Genrl,N
510,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
510,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
510,4,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
510,5,Respiration abnormal,Breathing abnormalities,Respiratory disorders NEC,Resp,N
511,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
512,1,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
512,2,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
512,3,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
513,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
513,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
513,3,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
513,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
513,5,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
513,6,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
513,7,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
513,8,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
513,9,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
513,10,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
514,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
514,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
514,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
515,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
516,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
516,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
516,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
516,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
517,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
517,2,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
517,3,Exposure via skin contact,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
517,4,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
518,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
518,2,Exposure via skin contact,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
518,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
518,4,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
518,5,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
519,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
519,2,Exposure via skin contact,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
519,3,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
519,4,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
520,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
520,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
520,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
520,4,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
521,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
521,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
522,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
522,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,Y
522,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
522,4,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
523,1,Headache,Headaches NEC,Headaches,Nerv,N
523,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
523,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
524,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
524,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
524,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
525,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
525,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
526,1,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
526,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
526,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
527,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
527,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
527,3,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
528,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
529,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
529,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
530,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
530,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
530,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
530,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
530,5,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
530,6,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
531,1,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
531,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
531,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
532,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
532,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
532,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
533,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
533,2,Cold burn,Thermal burns,Injuries by physical agents,Inj&P,N
533,3,Exposure via skin contact,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
534,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
534,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
534,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
534,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
534,5,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
535,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
535,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
536,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
536,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
536,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
536,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
536,5,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
537,1,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
537,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
538,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
538,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
539,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
539,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
539,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
540,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
540,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
540,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
540,4,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
540,5,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
540,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
541,1,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
542,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
543,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
544,1,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
545,1,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
545,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
546,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
546,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
546,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
547,1,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
548,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
548,2,Hypercapnia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
548,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
548,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
548,5,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
549,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
549,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
549,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
550,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
551,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
551,2,Cold burn,Thermal burns,Injuries by physical agents,Inj&P,N
551,3,Device leakage,Device issues NEC,Device issues,Prod,N
551,4,Occupational exposure to product,Occupational exposures,"Exposures, chemical injuries and poisoning",Inj&P,N
552,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
552,2,Cold burn,Thermal burns,Injuries by physical agents,Inj&P,N
552,3,Exposure via skin contact,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
552,4,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
553,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
553,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
554,1,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
554,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
554,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
555,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
555,2,Cold burn,Thermal burns,Injuries by physical agents,Inj&P,N
556,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
556,2,Exposure via skin contact,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
556,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
556,4,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
557,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
557,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
557,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
557,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
558,1,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
559,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
559,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
559,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
560,1,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
561,1,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
562,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
562,2,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
562,3,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
563,1,Cold burn,Thermal burns,Injuries by physical agents,Inj&P,N
563,2,Device leakage,Device issues NEC,Device issues,Prod,N
563,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
564,1,Cold burn,Thermal burns,Injuries by physical agents,Inj&P,N
564,2,Device issue,Device issues NEC,Device issues,Prod,N
564,3,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
564,4,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
565,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
565,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
565,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
565,4,Exposure via skin contact,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
565,5,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
566,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
566,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
566,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
566,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
567,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
568,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
568,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
568,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
